Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer (PACT-17)

This study has been terminated.
(concern of detrimental effect)
Information provided by (Responsible Party):
Michele Reni, IRCCS San Raffaele Identifier:
First received: July 21, 2010
Last updated: April 23, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2015
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)